SCHEMBL13975447

SCHEMBL13975447

COC(=O)c1cccc(S(=O)(=O)Nc2cc(C(C)C)cnc2OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 1/20 0.55
▸ ACLY P53396 3/20 0.52
▸ PIK3CG P48736 1/20 0.45
▸ TCF4 P15884 2/20 0.45
▸ CTNNB1 P35222 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ PIK3CA P42336 3/20 0.44
▸ MTOR P42345 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ BRD4 O60885 1/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ HSPD1 P10809 1/20 0.43
▸ PTPN2 P17706 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ PTPN5 P54829 1/20 0.43
▸ HSPE1 P61604 1/20 0.43
▸ PLAU P00749 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13976075 0.92 ACLY (0.53) SLC40A1ACLYPIK3CGALDH1A1MEN1
SCHEMBL13976112 0.86 SLC40A1 (0.58) SLC40A1ACLYPIK3CGTCF4CTNNB1
SCHEMBL24139843 0.85 SLC40A1 (0.57) SLC40A1ACLYPIK3CGTCF4CTNNB1
SCHEMBL24139765 0.84 SLC40A1 (0.56) SLC40A1ACLYPIK3CGTCF4CTNNB1
SCHEMBL19558829 0.83 ACLY (0.51) SLC40A1ACLYPIK3CGALDH1A1MEN1
SCHEMBL13975453 0.83 SLC40A1 (0.55) SLC40A1ACLYPIK3CGTCF4CTNNB1
SCHEMBL24137238 0.83 PIK3CG (0.45) PIK3CGPIK3CAMTOR
SCHEMBL24139986 0.82 KDM4E (0.48) SLC40A1ACLYALDH1A1MEN1KMT2A
SCHEMBL24140017 0.82 LMNA (0.51) ALDH1A1MEN1KMT2APIK3CALMNA
SCHEMBL24139918 0.79 TSHR (0.48) PIK3CGALDH1A1MEN1KMT2APIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2710018-B1 MACROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS FUNDACION CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III (ES) 2021-12-29 — — EP disclosed
WO-2012156756-A2 NEW COMPOUNDS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-11-22 — — WO disclosed
Send feedback